Skip to content
GovLens is in free beta — full access while we build. Join the beta →
← 🇫🇮 Eduskunta/ASIANTUNTIJALAUSUNTOfi-16492

HE 106/2015 vp StV 03.12.2015 Lääketeollisuus ry Asiantuntijalausunto

Stage otherUpdated 3d ago

This procedure concerns expert opinions on Finnish legislation related to pharmaceutical pricing, reimbursements, and pharmacy operations. It addresses patient co-payments, wholesale prices, and healthcare costs. The changes affect patients, healthcare providers, pharmacies, and the pharmaceutical industry in Finland, impacting the cost of medicines and related services.